Five years into his Alzheimer’s diagnosis, David Rothman had lost the ability to communicate. Silent and unresponsive, he seemed unreachable. But in 2023, a serendipitous moment changed everything. While in the lobby of his care...
A groundbreaking test known as qBEANS (Quick Behavioral Exam to Advance Neuropsychological Screening) is showing immense potential in identifying Alzheimer's disease early, as presented at the 2024 Gerontological Society of America Annual Scientific Meeting.
Recent findings from the American Heart Association (AHA) reveal critical insights into how cardiovascular conditions like heart failure (HF), atrial fibrillation (AF), and coronary heart disease (CHD) may heighten the risk for cognitive decline and...
Patients experiencing memory lapses often find themselves seeking a second opinion, especially when referred to specialists like Dr. David Jones, a neurologist at Mayo Clinic in Rochester, Minnesota. Many of these patients exhibit common memory...
As our parents age, there may come a time when living independently becomes challenging. Having a conversation about moving into assisted living can be a sensitive and emotional topic. It's crucial to approach this discussion...
In 2019, the estimated number of global dementia cases totaled 57.4 million. That number is expected to nearly triple by 2050. Given the predicted surge in incidence, and the lack of substantial treatment options, research...
• Donepezil (Aricept, Adlarity) is a first-line treatment for dementia caused by Alzheimer's disease. It can help those who have mild, moderate, or severe disease. • Aricept is a brand of donepezil that is taken orally. It comes...
